AAAAAA
Results:
1-22
|
Results: 22
Authors:
WOLLENBERG B
ZEIDLER R
LEBEAU A
MACK B
LANG S
Citation: B. Wollenberg et al., LACK OF B7.1 AND B7.2 ON HEAD AND NECK-CANCER CELLS AND POSSIBLE SIGNIFICANCE FOR GENE-THERAPY, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2(2), 1998, pp. 167-171
Authors:
SHIRMOHAMMADI D
WOLLENBERG B
VOJDANI A
SANDRIN P
PEREIRA M
RAHIMI F
SCHNEIDER T
STOTT B
Citation: D. Shirmohammadi et al., TRANSMISSION DISPATCH AND CONGESTION MANAGEMENT IN THE EMERGING ENERGY MARKET STRUCTURES, IEEE transactions on power systems, 13(4), 1998, pp. 1466-1474
Authors:
LANG S
VUJANOVIC NL
WOLLENBERG B
WHITESIDE TL
Citation: S. Lang et al., ABSENCE OF B7.1-CD28 CTLA-4-MEDIATED COSTIMULATION IN HUMAN NK CELLS/, European Journal of Immunology, 28(3), 1998, pp. 780-786
Authors:
ZEIDLER R
WOLLENBERG B
KASTENBAUER E
HAMMERSCHMIDT W
Citation: R. Zeidler et al., EPSTEIN-BARR-VIRUS-DERIVED PLASMIDS AS VECTORS FOR THE GENERATION OF CYTOTOXIC T-LYMPHOCYTES, British Journal of Cancer, 77, 1998, pp. 155-155
Authors:
ANDRATSCHKE M
CHAUBAL S
LANG S
ZEIDLER R
WOLLENBERG B
Citation: M. Andratschke et al., NEW DEFINITION OF THE TUMOR MARGIN BY THE EXPRESSION OF EP-CAM, British Journal of Cancer, 77, 1998, pp. 176-176
Authors:
LANG S
WHITESIDE T
ZEIDLER R
WOLLENBERG B
Citation: S. Lang et al., GENE-THERAPY OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK BY TRANSFECTION WITH THE B7.1 GENE, British Journal of Cancer, 77, 1998, pp. 1515-1515
Authors:
WOLLENBERG B
SCHMITT B
ERNDL S
LANG S
LINDHOFER H
KASTENBAUER E
ZEIDLER R
Citation: B. Wollenberg et al., A BISPECIFIC ANTIBODY INDUCES EFFICIENT KILLING OF TUMOR-CELLS - PHASE-I TRIAL IN PATIENTS WITH HNSCC, British Journal of Cancer, 77, 1998, pp. 1516-1516
Authors:
PAULI C
NAUJOKS K
MUNDL H
LANG S
ZEIDLER R
KASTENBAUER E
WOLLENBERG B
Citation: C. Pauli et al., GENE-THERAPY OF HNSCC WITH LIPOSOMAL MEDIATED H-IL2 PLASMIDS - PHASE-1 STUDY, British Journal of Cancer, 77, 1998, pp. 1517-1517
Authors:
WOLLENBERG B
JAN NV
JUND R
CHAUBAL S
UNTCH M
Citation: B. Wollenberg et al., UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR PLASMINOGEN-ACTIVATOR INHIBITOR-1 - NEW FUNCTIONAL RISK-FACTORS IN HEAD AND NECK SQUAMOUS-CELL CANCER, Oncology Reports, 4(4), 1997, pp. 853-855
Authors:
WOLLENBERG B
VONJAN N
SAUTIER W
HOFMANN K
SCHMITT UM
STIEBER P
Citation: B. Wollenberg et al., SERUM LEVELS OF INTERCELLULAR-ADHESION MOLECULE-1 IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Tumor biology, 18(2), 1997, pp. 88-94
Authors:
ZEIDLER R
REISBACH G
LANG S
WOLLENBERG B
SCHMITT B
ERNDL S
CHAUBAL S
LINDHOFER H
Citation: R. Zeidler et al., A BISPECIFIC ANTIBODY INDUCES EFFICIENT KILLING OF TUMOR-CELLS, European journal of cancer, 33, 1997, pp. 103-103
Authors:
LANG S
ZEIDLER R
WOLLENBERG B
WHITESIDE T
Citation: S. Lang et al., EXPRESSION OF B7.1 IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK ENHANCES PROLIFERATION AND CYTOTOXICITY OF ALLOGENEIC AND AUTOLOGOUS LYMPHOCYTES, European journal of cancer, 33, 1997, pp. 128-128
Authors:
WOLLENBERG B
LANG S
SCHMITT B
KASTENBAUER E
ZEIDLER R
Citation: B. Wollenberg et al., IN-VITRO STUDIES OF LIPOSOME-MEDIATED GENE-TRANSFER INTO HEAD AND NECK-CANCER CELL-LINES, European archives of oto-rhino-laryngology, 254, 1997, pp. 130-132
Authors:
WOLLENBERG B
SCHMIDT W
SCHMITT B
LANG S
ZEIDLER R
Citation: B. Wollenberg et al., RECEPTOR-MEDIATED GENE-TRANSFER INTO HEAD AND NECK SQUAMOUS-CELL CANCER, Laryngo-, Rhino-, Otologie, 76(7), 1997, pp. 411-414
Authors:
WOLLENBERG B
JAN NV
PITZKE P
REITER W
STIEBER P
Citation: B. Wollenberg et al., ANTI-P53 ANTIBODIES IN SERUM OF SMOKERS AND HEAD AND NECK-CANCER PATIENTS, Anticancer research, 17(1A), 1997, pp. 413-418
Authors:
LANG S
SCHILLING V
WOLLENBERG B
MACK B
NERLICH A
Citation: S. Lang et al., LOCALIZATION OF TRANSFORMING GROWTH FACTOR-BETA-EXPRESSING CELLS AND COMPARISON WITH MAJOR EXTRACELLULAR COMPONENTS IN AURAL CHOLESTEATOMA, The Annals of otology, rhinology & laryngology, 106(8), 1997, pp. 669-673
Authors:
WOLLENBERG B
NAUJOKS K
KASTENBAUER E
Citation: B. Wollenberg et al., CONSIDERATIONS OF SOMATIC GENE-THERAPY IN HEAD AND NECK SQUAMOUS-CELLCANCER, Laryngo-, Rhino-, Otologie, 75(6), 1996, pp. 356-362
Authors:
STIEBER P
WOLLENBERG B
SCHMITT UM
VONJAN N
HOFMANN K
FATEHMOGHADAM A
Citation: P. Stieber et al., CLINICAL RELEVANCE OF TUMOR-MARKERS IN HE AD AND NECK SQUAMOUS-CELL CARCINOMAS, Tumordiagnostik & Therapie, 17(4), 1996, pp. 116-121
Authors:
WOLLENBERG B
JAN V
SCHMIT UM
HOFMANN K
STIEBER P
FATEHMOGHADAM A
Citation: B. Wollenberg et al., CYFRA-21-1 IS NOT SUPERIOR TO SCC ANTIGEN AND CEA IN HEAD AND NECK SQUAMOUS-CELL CANCER, Anticancer research, 16(5B), 1996, pp. 3117-3124
Authors:
WOLLENBERG B
OLLESCH A
MAAG K
FUNKE I
WILMES E
Citation: B. Wollenberg et al., MICROMETASTASES IN BONE-MARROW OF PATIENT S WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Laryngo-, Rhino-, Otologie, 73(2), 1994, pp. 88-93
Authors:
WOLLENBERG B
MULLERHOCKER J
WUSTROW TPU
Citation: B. Wollenberg et al., LEIOMYOSARCOMA OF THE TONGUE - A CASE-REP ORT, Laryngo-, Rhino-, Otologie, 72(7), 1993, pp. 342-345
Authors:
GUTMANN R
WOLLENBERG B
KRAMPERT B
MEES K
Citation: R. Gutmann et al., DOPPLER SONOGRAPHIC EVALUATION OF FUNCTIO NAL-DISORDERS OF THE CERVICAL ARTERIES IN PATIENTS WITH COCHLEAR AND VESTIBULAR PROBLEMS, Laryngo-, Rhino-, Otologie, 72(10), 1993, pp. 502-505
Risultati:
1-22
|